View in EDS HTML Full Text PDF Full Text

Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6-11 Years of Age with Severe Atopic Dermatitis.

Saved in:
Bibliographic Details
Title: Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6-11 Years of Age with Severe Atopic Dermatitis.
Authors: Cork MJ; Sheffield Dermatology Research, University of Sheffield, Sheffield, UK.; Sheffield Children's Hospital Clinical Research Facility, Sheffield, UK., Thaçi D; Institute and Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany., Eichenfield LF; Departments of Dermatology and Pediatrics, University of California, San Diego, CA, USA.; Division of Pediatric and Adolescent Dermatology, Rady Children's Hospital, San Diego, CA, USA., Arkwright PD; Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK., Chen Z; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Thomas RB; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Kosloski MP; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Dubost-Brama A; Sanofi, Chilly-Mazarin, France., Prescilla R; Sanofi, Cambridge, MA, USA., Bansal A; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Levit NA; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA. noah.a.levit@gmail.com.
Source: Dermatology and therapy [Dermatol Ther (Heidelb)] 2023 Nov; Vol. 13 (11), pp. 2697-2719. Date of Electronic Publication: 2023 Sep 26.
Publication Type: Journal Article
Journal Info: Publisher: Springer Healthcare Communications Country of Publication: Switzerland NLM ID: 101590450 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8210 (Print) NLM ISO Abbreviation: Dermatol Ther (Heidelb) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37750994
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6-11 Years of Age with Severe Atopic Dermatitis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Cork+MJ%22">Cork MJ</searchLink>; Sheffield Dermatology Research, University of Sheffield, Sheffield, UK.; Sheffield Children's Hospital Clinical Research Facility, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Thaçi+D%22">Thaçi D</searchLink>; Institute and Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany.<br /><searchLink fieldCode="AU" term="%22Eichenfield+LF%22">Eichenfield LF</searchLink>; Departments of Dermatology and Pediatrics, University of California, San Diego, CA, USA.; Division of Pediatric and Adolescent Dermatology, Rady Children's Hospital, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Arkwright+PD%22">Arkwright PD</searchLink>; Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Chen+Z%22">Chen Z</searchLink>; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Thomas+RB%22">Thomas RB</searchLink>; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Kosloski+MP%22">Kosloski MP</searchLink>; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Dubost-Brama+A%22">Dubost-Brama A</searchLink>; Sanofi, Chilly-Mazarin, France.<br /><searchLink fieldCode="AU" term="%22Prescilla+R%22">Prescilla R</searchLink>; Sanofi, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Bansal+A%22">Bansal A</searchLink>; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Levit+NA%22">Levit NA</searchLink>; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA. noah.a.levit@gmail.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101590450%22">Dermatology and therapy</searchLink> [Dermatol Ther (Heidelb)] 2023 Nov; Vol. 13 (11), pp. 2697-2719. <i>Date of Electronic Publication: </i>2023 Sep 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Healthcare+Communications%22">Springer Healthcare Communications </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101590450 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2193-8210 (Print) <i>NLM ISO Abbreviation: </i>Dermatol Ther (Heidelb) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37750994
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s13555-023-01016-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2697
    Titles:
      – TitleFull: Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6-11 Years of Age with Severe Atopic Dermatitis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cork MJ
      – PersonEntity:
          Name:
            NameFull: Thaçi D
      – PersonEntity:
          Name:
            NameFull: Eichenfield LF
      – PersonEntity:
          Name:
            NameFull: Arkwright PD
      – PersonEntity:
          Name:
            NameFull: Chen Z
      – PersonEntity:
          Name:
            NameFull: Thomas RB
      – PersonEntity:
          Name:
            NameFull: Kosloski MP
      – PersonEntity:
          Name:
            NameFull: Dubost-Brama A
      – PersonEntity:
          Name:
            NameFull: Prescilla R
      – PersonEntity:
          Name:
            NameFull: Bansal A
      – PersonEntity:
          Name:
            NameFull: Levit NA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2023 Nov
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 2193-8210
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Dermatology and therapy
              Type: main
ResultId 1